On This Page

Filter

These are the filters currently being used to limit the search results. Click on the
icon to remove the filter.

min answer › question first answered

2014-11-03T11:58:34.5403704Z

max date

2018-11-02

Sort by

This list shows the properties that you can sort by. Click on to sort in ascending order and to sort in descending order. The properties that you're currently sorting by are
shown at the top of the list. Click on to remove a sort and or to reverse the current sort order. Click on the icon to remove all the sorting. Note that sorting can significantly slow down the
loading of the page.

View

Choose what information you want to view about each item. There are some pre-defined
views, but starred properties are always present no matter what the view. You can
star properties by clicking on the icon. The currently starred icons have a icon; clicking on it will unstar the property.

To ask Her Majesty's Government what measures they have taken to ensure that the South
Sudanese authorities conducted a satisfactory investigation in relation to the killing
of the British citizen, Christopher Allen, in August 2017.

<p>​US consular services contacted the Foreign and Commonwealth Office for advice
regarding Christopher Allen’s death in South Sudan, a dual US/UK national. Consular
assistance was provided by the US consular services in Sudan and the USA, following
the decision by the family to repatriate Mr Allen to the USA.</p>

<p>​US consular services contacted the Foreign and Commonwealth Office for advice
regarding Christopher Allen’s death in South Sudan, a dual US/UK national. Consular
assistance was provided by the US consular services in Sudan and the USA, following
the decision by the family to repatriate Mr Allen to the USA.</p>

<p>​US consular services contacted the Foreign and Commonwealth Office for advice
regarding Christopher Allen’s death in South Sudan, a dual US/UK national. Consular
assistance was provided by the US consular services in Sudan and the USA, following
the decision by the family to repatriate Mr Allen to the USA.</p>

<p>The Parliamentary under Secretary of State (Steve Brine MP) commissioned Public
Health England (PHE) to review the evidence for dependence on, and withdrawal from,
prescribed medicines. The review was launched in January 2018 and is due to report
in spring 2019 and we await its findings. It is the responsibility of local authorities
to commission services, such as the provision of withdrawal centres for addiction
to prescribed medicines, to meet assessed local need. The Government currently has
no plans to increase the number of these centres.</p><p>The Government has no plans
to introduce a separate national helpline to support people affected by prescribed
drug dependence. Help and advice on prescribed drug dependence is already available
from the 111 helpline or NHS Choices. People who feel that they might be dependent
on either prescribed or over the counter medicines should seek help from a health
professional in the first instance (such as a general practitioner or pharmacist).</p><p>PHE’s
review includes prescribed benzodiazepine drug dependence but will not consider evidence
further back than 10 years ago. There are no plans to establish a public inquiry into
prescribed benzodiazepine drug dependence.</p>

<p>The Parliamentary under Secretary of State (Steve Brine MP) commissioned Public
Health England (PHE) to review the evidence for dependence on, and withdrawal from,
prescribed medicines. The review was launched in January 2018 and is due to report
in spring 2019 and we await its findings. It is the responsibility of local authorities
to commission services, such as the provision of withdrawal centres for addiction
to prescribed medicines, to meet assessed local need. The Government currently has
no plans to increase the number of these centres.</p><p>The Government has no plans
to introduce a separate national helpline to support people affected by prescribed
drug dependence. Help and advice on prescribed drug dependence is already available
from the 111 helpline or NHS Choices. People who feel that they might be dependent
on either prescribed or over the counter medicines should seek help from a health
professional in the first instance (such as a general practitioner or pharmacist).</p><p>PHE’s
review includes prescribed benzodiazepine drug dependence but will not consider evidence
further back than 10 years ago. There are no plans to establish a public inquiry into
prescribed benzodiazepine drug dependence.</p>

To ask Her Majesty's Government whether they will ensure that in establishing a 24
hour helpline for people affected by prescribed medicines addiction they will also
ensure that adequate services are in place to refer patients to.

<p>The Parliamentary under Secretary of State (Steve Brine MP) commissioned Public
Health England (PHE) to review the evidence for dependence on, and withdrawal from,
prescribed medicines. The review was launched in January 2018 and is due to report
in spring 2019 and we await its findings. It is the responsibility of local authorities
to commission services, such as the provision of withdrawal centres for addiction
to prescribed medicines, to meet assessed local need. The Government currently has
no plans to increase the number of these centres.</p><p>The Government has no plans
to introduce a separate national helpline to support people affected by prescribed
drug dependence. Help and advice on prescribed drug dependence is already available
from the 111 helpline or NHS Choices. People who feel that they might be dependent
on either prescribed or over the counter medicines should seek help from a health
professional in the first instance (such as a general practitioner or pharmacist).</p><p>PHE’s
review includes prescribed benzodiazepine drug dependence but will not consider evidence
further back than 10 years ago. There are no plans to establish a public inquiry into
prescribed benzodiazepine drug dependence.</p>

<p>The Parliamentary under Secretary of State (Steve Brine MP) commissioned Public
Health England (PHE) to review the evidence for dependence on, and withdrawal from,
prescribed medicines. The review was launched in January 2018 and is due to report
in spring 2019 and we await its findings. It is the responsibility of local authorities
to commission services, such as the provision of withdrawal centres for addiction
to prescribed medicines, to meet assessed local need. The Government currently has
no plans to increase the number of these centres.</p><p>The Government has no plans
to introduce a separate national helpline to support people affected by prescribed
drug dependence. Help and advice on prescribed drug dependence is already available
from the 111 helpline or NHS Choices. People who feel that they might be dependent
on either prescribed or over the counter medicines should seek help from a health
professional in the first instance (such as a general practitioner or pharmacist).</p><p>PHE’s
review includes prescribed benzodiazepine drug dependence but will not consider evidence
further back than 10 years ago. There are no plans to establish a public inquiry into
prescribed benzodiazepine drug dependence.</p>

To ask Her Majesty's Government what training health visitors receive to enable them
to identify incipient and actual cases of ante-natal depression, post-natal depression,
and other maternal mental health issues.

<p>Health visitors are part of the nursing profession and regulated by the Nursing
and Midwifery Council (NMC). Health visitors are qualified and registered nurses or
midwives who have undertaken an approved training programme in Specialist Community
Public Health Nursing - Health Visiting.</p><p>The NMC has the general function of
promoting high standards of education and coordinating all stages of education to
ensure that health visitors are equipped with the knowledge, skills and attitudes
essential for professional practice, including continuous professional development
(CPD). The NMC set the standards of education and training for the nursing profession
expected at undergraduate and postgraduate level and approve curricula set by individual
higher education institutes. In so doing, they set out the knowledge, skills and behaviours
that both postgraduate and undergraduate nurses must be able to demonstrate.</p><p>CPD
is a term used to describe a number of different training and development activities
which may be required for the purposes of professional practice in the National Health
Service. The NMC requires 35 hours of CPD relevant to scope of practice in the three
year period since registration was last renewed, or joining the register.</p><p>The
NMC are in the process of rewriting their standards. For example, in the new pre-registration
nursing standards the NMC specify that registrants must have proficiencies in identifying
risk and vulnerability, in all settings and across the lifespan and would expect post-natal
depression to be included in the curriculum.</p>

To ask Her Majesty's Government what continuous professional development health visitors
are required to undertake to enable them to identify incipient and actual cases of
ante-natal depression, post-natal depression, and other maternal mental health issues.

<p>Health visitors are part of the nursing profession and regulated by the Nursing
and Midwifery Council (NMC). Health visitors are qualified and registered nurses or
midwives who have undertaken an approved training programme in Specialist Community
Public Health Nursing - Health Visiting.</p><p>The NMC has the general function of
promoting high standards of education and coordinating all stages of education to
ensure that health visitors are equipped with the knowledge, skills and attitudes
essential for professional practice, including continuous professional development
(CPD). The NMC set the standards of education and training for the nursing profession
expected at undergraduate and postgraduate level and approve curricula set by individual
higher education institutes. In so doing, they set out the knowledge, skills and behaviours
that both postgraduate and undergraduate nurses must be able to demonstrate.</p><p>CPD
is a term used to describe a number of different training and development activities
which may be required for the purposes of professional practice in the National Health
Service. The NMC requires 35 hours of CPD relevant to scope of practice in the three
year period since registration was last renewed, or joining the register.</p><p>The
NMC are in the process of rewriting their standards. For example, in the new pre-registration
nursing standards the NMC specify that registrants must have proficiencies in identifying
risk and vulnerability, in all settings and across the lifespan and would expect post-natal
depression to be included in the curriculum.</p>

To ask Her Majesty’s Government whether they will place in the Library of the House
any publications resulting from the phase 3 clinical trials approved for the potential
treatment of systemic amyloidosis or multiple myeloma; and what is the National Institute
of Health Research’s assessment of progress in these areas.

<p>There are four trials for systemic amyloidosis that are designated as ‘ongoing’
in the United Kingdom. These are being conducted by two commercial sponsors, Millennium
Pharmaceuticals Inc and A.T. Development Switzerland Sarl (two studies), and one non-commercial
sponsor, European Myeloma Network.</p><p> </p><p> </p><p> </p><p>Clinical trial sponsors
are required to publish a summary of their trial results to the EU Clinical Trials
Register within one year of their trial completing. At that point, these results will
become publically available on the EU Clinical Trials Register</p><p> </p><p> </p><p>
</p><p>The Department of Health, which funds the National Institute for Health Research
(NIHR), is a member of the National Cancer Research Institute (NCRI). NCRI Clinical
Studies Groups (CSGs) bring together clinicians, scientists, statisticians and lay
representatives to coordinate development of a strategic portfolio of trials within
their field. All CSGs interact with clinical research networks, funders (including
NIHR) and researchers to develop studies aimed at improving outcomes for patients.
The Haematological Oncology CSG has a Myeloma Subgroup and its 2013-14 annual report
that includes an assessment of progress in these areas is attached and available on
the NCRI website at:</p><p> </p><p><a href="http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf"
target="_blank">http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf</a>.</p><p>
</p><p> </p><p> </p><p>We cannot comment on commercial considerations. When the results
are known, the commercial potential of these trial’s products will be a matter for
the respective trial sponsors.</p><p> </p>